CIPLORIC 100

29% OFF

Original price was: ₹21.16.Current price is: ₹15.00.

CIPLORIC 100
Salt Composition: Allopurinol (100mg)
Company: Cipla Ltd

10.0 tablets in 1 strip

Buy Now
Category:

Description

Ciploric 100 Tablet is a medicine manufactured by Cipla Ltd that contains Allopurinol (100mg) as its active ingredient. It is commonly prescribed for the management of gout and high uric acid levels in the blood (a condition known as hyperuricemia).

How it Works:
Allopurinol belongs to a class of drugs called xanthine oxidase inhibitors. It works by reducing the production of uric acid in the body. When uric acid levels become too high, they can form sharp crystals in the joints and tissues, leading to gout attacks, joint pain, swelling, and kidney stones. By lowering uric acid levels, Ciploric 100 helps in preventing these complications.

Uses of Ciploric 100:

  • Treatment and prevention of gout attacks

  • Management of chronic hyperuricemia

  • Prevention of uric acid kidney stones

  • Used in certain types of cancer therapy (to prevent uric acid buildup during chemotherapy)

Key Benefits:

  • Reduces uric acid production in the body

  • Prevents painful gout attacks and joint inflammation

  • Helps avoid kidney stone formation due to uric acid

  • Improves quality of life in patients with chronic gout

Dosage & Administration:

  • Usually taken once daily after meals with a full glass of water, or as directed by the doctor.

  • Adequate fluid intake is recommended to prevent kidney stone formation.

  • Dosage may be adjusted depending on the patient’s uric acid levels and response to therapy.

Safety & Precautions:

  • Should be taken under medical supervision.

  • Inform your doctor if you have kidney or liver problems.

  • May cause side effects like rash, stomach upset, or drowsiness in some patients.

  • Avoid alcohol, as it may increase uric acid levels and worsen gout.

  • Not recommended during pregnancy and breastfeeding unless prescribed.

Leave a Reply

Your email address will not be published. Required fields are marked *